4.7 Article

The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

Journal

LEUKEMIA
Volume 33, Issue 2, Pages 546-549

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41375-018-0272-0

Keywords

-

Funding

  1. Research Fund at Rigshospitalet, Copenhagen

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available